Both in Pharmaceuticals
Oramed Pharmaceuticals vs PepGen
Over the past year ORMP returned +69.5% and PEPG returned −48.1%; their daily moves had a correlation of 0.06.
ORMP +69.5% PEPG −48.1%Growth of $1, one year, split-adjusted
| Metric | ORMP | PEPG |
|---|---|---|
| Price | $4.00 | $2.35 |
| Market cap | $166.4M | $162.8M |
| Today | −2.68% | −0.42% |
| 1 month | −10.9% | +3.1% |
| 6 months | +1.8% | +30.6% |
| Year to date | +40.4% | −63.9% |
| 1 year | +66.7% | −48.1% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | 1.0× | — |
| Price / sales | — | — |
| Net cash | $50.6M | $117.2M |
| Dividend yield | 6.25% | — |
| Volatility (60d) | 36.2% | 68.0% |
| Short % of float | 4.3% | 9.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).